The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUA) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines. This update included authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals 6 months of age and older, including for an additional dose or doses for certain populations.
COVID-19 Vaccine Information
COVID-19 Vaccines
On April 18, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUA) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines. This update included authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals six months of age and older, including for an additional dose or doses for certain populations.
The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
Most individuals may receive a single dose of a bivalent vaccine. Certain individuals may be eligible for additional doses depending on age and immunocompromised status. Most unvaccinated individuals may receive a single dose of a bivalent vaccine, rather than multiple doses of the original monovalent mRNA vaccines.
Latest Vaccine Updates
4/18/23
10/7/22
State Surgeon General Dr. Joseph A. Ladapo has announced new guidance regarding mRNA vaccines. The Florida Department of Health conducted an analysis through a self-controlled case series, which is a technique originally developed to evaluate vaccine safety. This analysis found that there is an 84% increase in the relative incidence of cardiac-related death among males 18-39 years old within 28 days following mRNA vaccination.
8/31/22
The U.S. Food and Drug Administration updated the emergency use authorizations of the Pfizer-BioNTech and the Moderna vaccine for administration of a single booster at least two months after a primary or booster dose is given to help protect against the COVID-19 omicron variant. Adults aged 18 and up are eligible to receive the Moderna booster, while anyone 12 and up are eligible to receive the Pfizer-BioNTech booster.
3/8/22
Based on currently available data, healthy children aged 5-17 may not benefit from receiving the currently available COVID-19 vaccine. The Florida Department of Health recommends that children with underlying conditions are the best candidates for the COVID-19 vaccine.
1/24/22
The U.S. Food and Drug Administration (FDA) revised the Emergency Use Authorizations (EUA) for Eli Lilly’s bamlanivimab-etesevimab and Regeneron’s REGEN-COV monoclonal antibody treatments, discontinuing their use by any U.S. state or jurisdiction.
Find COVID-19 vaccination sites near you.
Appointments may be required, and specific vaccine types and brands may not be available at all sites.
Search Now